VA Opioid Prescription Policy, Practice and Procedures
If you are having trouble viewing this hearing, please try the following steps:
- Clear your browser's cache - Guide to clearing browser cache
- Close and re-open your browser
- If the above two steps do not help, please try another browser. Google Chrome and Microsoft Edge have the highest level of compatibility with our player.
Agenda
Panel I
Carolyn Clancy, MD, Interim Under Secretary for Health, Veterans Health Administration,
Department of Veterans Affairs
Accompanied By:
Gavin West, MD, Special Assistant for Clinical Operations
Michael Valentino, Chief Consultant of Pharmacy Benefits Management Services
John D. Daigh, Jr., MD, CPA, Assistant Inspector General for Healthcare Inspections,
Office of Inspector General, Department of Veterans Affairs
--
Panel II
G. Caleb Alexander, MD, Co-Director, Center for Drug Safety and Effectiveness,
Johns Hopkins Bloomberg School of Public Health
Carol Forster, MD, Physician Director, Pharmacy & Therapeutics/Medication Safety,
Mid-Atlantic Permanente Medical Group, Kaiser Permanente
John Gadea, Director, Drug Control Division, Connecticut Department of Consumer Protection
--
Member Statements
-
Senator Richard Blumenthal (D-CT)
-
Chairman Johnny Isakson (R-GA)
Testimony
-
Dr. Carolyn Clancy
Deputy Under Secretary for HealthVeterans Health Administration, Department of Veterans AffairsDownload File (52.53 KB) -
Dr. John D. Daigh
Assistant Inspector General for Healthcare InspectionsOffice of the Inspector General, Department of Veterans AffairsDownload File (76.94 KB) -
Dr. G. Caleb Alexander
Co-DirectorCenter for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public HealthDownload File (1.25 MB) -
Dr. Carol Forster
Physician Director, Pharmacy & Therapeutics/Medication SafetyMid-Atlantic Permanente Medical Group, Kaiser PermanenteDownload File (56.65 KB) -
Mr. John Gadea
DirectorDrug Control Division, Connecticut Department of Consumer ProtectionDownload File (114.87 KB)
